Epilepsy, Drug Resistant Clinical Trial
Official title:
Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel-group Trial
The primary objective of this research is to study the efficacy and safety of deep brain stimulation (DBS) of subthalamic nucleus (STN) as adjunctive therapy for reducing the frequency of seizures in drug-resistant focal motor epilepsy.
This is a multicenter, randomized, double-blind, sham-controlled, parallel-group trial that aims to investigate the efficacy of STN-DBS in reducing the frequency of seizures in drug-resistant focal motor epilepsy. Participants who were eligible for the inclusion criteria and ineligible for the exclusion criteria will be randomly assigned into two groups by a 1:1 ratio. The primary purpose of this study is to compare active STN-DBS with sham STN-DBS in reducing seizure frequency. Both intent analysis (ITT) and compliance program set (PPS) were used for analysis. Only high-volume centers with a proven track record will be included. The STEM trial will be conducted in 5 sites in China. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03183076 -
Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy
|
N/A | |
| Completed |
NCT04181229 -
Deep Brain Stimulation Post Failed Vagal Nerve Stimulation
|
N/A | |
| Recruiting |
NCT04673071 -
Effectiveness and Safety of Thread Embedding Acupuncture for Drug Resistant Epilepsy
|
N/A | |
| Recruiting |
NCT04166305 -
Drug Resistant Epilepsy: Clinical and Genetic Study
|
||
| Not yet recruiting |
NCT06364085 -
Enhancing Epilepsy Management With Precision Deep Brain Stimulation
|
N/A | |
| Completed |
NCT03860298 -
Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy
|
N/A |